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4Background
Atrial myxomas, the most common type of cardiac tumors, can 
cause life-threatening complications. As most cardiac myxomas 
are surgically curable, early diagnosis is crucial. Cardiac tumors 
can present with cardiac and embolic manifestations, and should 
be considered in the differential diagnosis of patients presenting 
with such symptoms. In this case report, we describe a young, 
healthy patient who presented with stroke symptoms secondary 
to embolic atrial myxoma.
Case Presentation
A 45-year-old male with no past medical history presented with 
an acute onset of dysarthria, described as garbled speech. He also 
experienced weakness and heaviness of his right hand, which 
impaired his ability to brush his teeth and write. He denied 
left-handed or lower extremity weakness, head trauma, facial 
droop, dysphagia, migraines, diplopia/visual changes, confusion, 
or memory loss. He denied tobacco, alcohol, or drug use. Review 
of systems was otherwise negative, although the patient reported 
that whenever he participated in strenuous physical activity over 
the past few years, he would become nauseated. 
Investigations
The patient initially presented to an outside hospital after his 
symptoms persisted for over 24 hours. Computed tomography 
(CT) of the head was negative for intracranial bleed and he 
was discharged. While his dysarthria improved, he continued 
to have weakness and went to another hospital for evaluation. 
Brain magnetic resonance imaging (MRI) at the second hospital 
showed two acute left basal ganglia infarcts. As part of the 
stroke workup, he had an echocardiogram, which revealed a 5 
cm left atrial myxoma. He was transferred to Thomas Jefferson 
University Hospital (TJUH) for further management. 
On presentation to the TJUH Cardiac Critical Care Unit (CCU), 
the patient’s vital signs were as follows: temperature 98.2°F, blood 
pressure 142/80 mm Hg, pulse 100 beats per minute, respiratory 
rate 19 breaths per minute. Cardiac examination was notable for 
a soft diastolic rumble heard best in the left upper parasternal 
area. Neurological examination revealed minor dysarthria. The 
remainder of the physical examination was normal. Complete 
blood count and basic metabolic panel were within normal 
limits, and electrocardiogram showed sinus rhythm. C-reactive 
protein (CRP) was elevated to 7.9 mg/dL. Chest radiograph was 
unremarkable. CT head showed left basal ganglia and corona 
radiata hypodensities consistent with recent infarction. CT 
thorax revealed a hypoattenuating 3.7 x 2.4 cm lesion in the left 
atrium. Transesophageal echocardiogram (TEE) confirmed a 
large (5 x 3.2 cm), irregular, gelatinous mass, with frond-like, 
mobile edges attached to the fossa ovalis, and broad 1 cm stalk. 
This mass prolapsed into the mitral valve orifice during diastole, 
likely representing a left atrial myxoma. 
Treatment
Four days after presentation to TJUH, the patient underwent 
robotic-assisted excision of the myxoma. There were no intraop-
erative complications, and post-procedure TEE revealed resolution 
of the left atrial myxoma without mitral valvular insufficiency. 
The patient required pressors and inotropic support for 2 days 
post-operatively for persistent hypotension. He was discharged 
home in stable condition on post-operative day #3.
Discussion
Myxomas, the most common type of benign primary cardiac 
tumor, account for approximately one-third of benign tumors 
of the heart.1-3 They occur across all age groups, more commonly 
in women and during the third through sixth decades.1,4-7 90% 
of cases are sporadic, while the remainder are transmitted in an 
autosomal dominant fashion. This inheritance typically occurs 
as part of the Carney syndrome complex that includes myxomas, 
lentigines/pigmented nevi, and endocrine overactivity.1,8-12 
The NAME (nevi, atrial myxoma, myxoid neurofibroma, 
and ephelides) and LAMB (lentigines, atrial myxoma, and 
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blue nevi) syndromes likely represent subsets of the Carney 
complex.1,13 While the genetic origin of the Carney complex is 
unclear, patients frequently have inactivating mutations of the 
PRKAR1A tumor-suppressor gene.1,13
Most myxomas arise in the left atrium from the interatrial 
septum near the fossa ovalis.4,14 They are gelatinous structures 
comprised of myxoma cells in a glycosaminoglycan-rich 
stroma, often pedunculated on a fibrovascular stalk.1,14,15 They 
arise from multipotent mesenchymal cells that persist from 
embryonic cardiac septation and have been found to produce 
vascular endothelial growth factor (VEGF), which is implicated 
in the early stages of tumor growth.13-16
Depending on location, myxomas can cause the signs and 
symptoms of corresponding valvular disease; atrial myxomas 
can mimic atrioventricular (AV) valve stenosis due to valve 
obstruction, while ventricular myxomas can cause outflow 
obstruction similar to subaortic or subpulmonic stenosis.1,3 
Diastolic murmurs result from obstruction of the filling 
ventricle, while systolic murmurs arise when valve closure or 
outflow is interrupted.3 The characteristic “diastolic tumor 
plop,” a low-pitched sound during early to mid-diastole, is 
thought to represent the physical impact of the tumor hitting 
the AV valve or ventricular wall.1 Repetitive trauma to the valve 
may also cause damage and regurgitation due to a “wrecking 
ball” phenomenon.17 Congestive heart failure (CHF) may result 
from obstruction of cardiac flow and/or impaired contractility 
from direct invasion of the myocardium (myocardial damage 
may also cause arrhythmias, heart block, pericardial effusion 
or tamponade).2,18,19 Symptoms may provide a clue to the 
tumor’s location: left-sided tumors may present with dyspnea 
on exertion, orthopnea or flash pulmonary edema; right-sided 
tumors may present with syncope, sudden death or right 
heart failure.2, 18-21 Of note, these symptoms can be sudden 
and/or positional due to the effect of gravity on the tumor’s 
position.1,2,18,19 Fragments of myxomas may embolize and cause 
signs of peripheral or pulmonary emboli, as well as fever, weight 
loss, malaise, arthralgias, rash, digital clubbing, and Raynaud’s 
phenomenon.1,2,22-28 Laboratory abnormalities associated with 
myxomas include anemia, leukocytosis, thrombocytopenia/
cytosis, elevated erythrocyte sedimentation rate (ESR) and 
CRP.1,2,22 Rarely, myxomas may become infected; the incidence 
of cerebral and systemic emboli from infected myxomas is 
greater than that from non-infected myxomas.29 Management of 
these patients is often complicated by bacteremia, septic shock, 
disseminated intravascular coagulation (DIC), multi-organ 
failure, and cerebral infarction.30
Echocardiography is useful in diagnosing myxomas; tumor size, 
shape, and attachment can be assessed, all of which assist in 
surgical planning for excision.1,3,18,31 TEE offers superior imaging 
compared to transthoracic echocardiography (TTE) owing to 
the proximity of the esophagus to the heart and use of high 
frequency transducers.31 Cardiac CT and MRI offer noninvasive 
imaging options that can also help evaluate the character-
istics of myxomas.1,2 In the past, cardiac catheterization and 
angiography were routinely performed prior to excision; their 
role has diminished in favor of noninvasive imaging due to the 
additional risk of tumor embolization during catheterization.1,32
Definitive treatment for a myxoma is surgical excision; medical 
therapy is only indicated for management of concomitant CHF 
and/or arrhythmias.1,33,34 Septal defects and/or valvular damage 
that occur during surgery may require repair.33,34 A potential 
complication of excision is fragmentation and embolization of 
part of the tumor.33,34 While thrombolytic therapy is reasonable 
for stroke secondary to blood clot emboli from cardiac myxomas, 
it has little effect on emboli composed of actual tumor.35 Overall 
post-surgical prognosis is excellent, with a 3% rate of operative 
mortality.1,19,33,34 Recurrence is rare in sporadic cases (1-2%) and 
usually due to inadequate resection; familial myxomas recur in 
12-22% of cases and are likely due to multifocal lesions.1,2,19,27 
Follow-up includes routine semi-annual echocardiography. 
Screening of first-degree relatives is appropriate due to the 
possibility of familial inheritance.1
Key Points
Although an uncommon cause of stroke, cardiac myxoma should 
be considered in the differential diagnosis. Definitive treatment 
is surgical resection, which offers excellent cure rates with rare 
recurrence and low mortality. Medical management is supportive. 
Once a cardiac myxoma has been identified, arrangements for 
surgical resection should be made immediately.
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